Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Terminated 2Active not recruiting 2Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Ovarian Neoplasms 1423Uterine Cervical Neoplasms 926Endometrial Neoplasms 493Carcinoma, Ovarian Epithelial 426Breast Neoplasms 425Fallopian Tube Neoplasms 413Neoplasms 274Uterine Cervical Dysplasia 208Colorectal Neoplasms 170Carcinoma, Non-Small-Cell Lung 168Pancreatic Neoplasms 156Prostatic Neoplasms 153Lung Neoplasms 151Stomach Neoplasms 126Peritoneal Neoplasms 119Sarcoma 117Uterine Neoplasms 112Melanoma 111Urinary Bladder Neoplasms 108Papillomavirus Infections 107Colonic Neoplasms 106Head and Neck Neoplasms 105Vulvar Neoplasms 101Esophageal Neoplasms 100Recurrence 95Testicular Neoplasms 91Carcinoma, Renal Cell 89Vaginal Neoplasms 79Small Cell Lung Carcinoma 77Kidney Neoplasms 74

Interventions

Paclitaxel 1Diphenhydramine 1Dexamethasone 1Cimetidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cystadenocarcinoma, Serous × Gynecologic × Clear all
NCT00515073 2014-07-03

Papillary Serous Carcinoma of the Endometrium

M.D. Anderson Cancer Center

Phase 2 Completed
30 enrolled 5 charts
Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡